...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Epigenetics market size

https://finance.yahoo.com/news/epigenetics-market-expected-reach-4-123000921.html

 

https://markets.businessinsider.com/news/stocks/epigenetics-market-to-reach-usd-19-12-billion-by-2026-reports-and-data-1028604293

 

 

Interesting that the entire market values  for Epigenetics has fallen from an expected   $19.12 Billon 2019 to $4.3 Billin  in 2026 and not a whisper of  a name from Zenith or Resverlogix. ....  

Still waiting for that allusive deal...

DM where's your 8 year lead ....... your management skills are as good as your academic qualifications 

 

 

 

 

6
Jan 16, 2024 02:18PM
1
Jan 16, 2024 07:41PM
2
Jan 22, 2024 01:01PM
1
Jan 22, 2024 02:46PM
3
Jan 25, 2024 11:48AM
Share
New Message
Please login to post a reply